These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 16142850)

  • 1. D-hormones for prevention of bone loss after organ transplant.
    Sambrook PN
    J Rheumatol Suppl; 2005 Sep; 76():41-3. PubMed ID: 16142850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attempted randomized controlled trial of pamidronate versus calcium and calcitriol supplements for management of steroid-induced osteoporosis in children and adolescents.
    Brown JJ; Zacharin MR
    J Paediatr Child Health; 2005 Nov; 41(11):580-2. PubMed ID: 16398842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Perspective for development of parathyroid hormone and related compounds as therapeutic agents for osteoporosis].
    Ikeda K; Fukagawa M
    Nihon Rinsho; 2005 Oct; 63 Suppl 10():367-71. PubMed ID: 16279664
    [No Abstract]   [Full Text] [Related]  

  • 4. Post-transplantation osteoporosis.
    Stein E; Ebeling P; Shane E
    Endocrinol Metab Clin North Am; 2007 Dec; 36(4):937-63; viii. PubMed ID: 17983930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of bone loss after organ transplantation.
    Cohen A; Sambrook P; Shane E
    J Bone Miner Res; 2004 Dec; 19(12):1919-32. PubMed ID: 15537434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug insight: the use of bisphosphonates for the prevention and treatment of osteoporosis in men.
    Brown SA; Guise TA
    Nat Clin Pract Urol; 2007 Jun; 4(6):310-20. PubMed ID: 17551535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Medical prophylaxis and treatment of steroid induced osteoporosis].
    Rødevand E; Mikkelsen K; Nordvåg BY; Haga HJ; Førre Ø; Johnsen V; Kvien TK
    Tidsskr Nor Laegeforen; 2005 Jun; 125(12):1643-5. PubMed ID: 15976829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical evaluation of novel bisphosphonate dosing regimens in osteoporosis: the role of comparative studies and implications for future studies.
    Cosman F; Borges JL; Curiel MD
    Clin Ther; 2007 Jun; 29(6):1116-27. PubMed ID: 17692726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corticosteroids: no drug prevention of fractures needed.
    Prescrire Int; 2009 Aug; 18(102):175. PubMed ID: 19746563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Secondary osteoporosis. Glucocorticoid induced osteoporosis in childhood : prophylaxis and treatment].
    Tanaka H
    Clin Calcium; 2007 Jul; 17(7):1114-9. PubMed ID: 17607080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The successful development of bisphosphonates in the therapy of osteoporosis].
    Fassbender WJ; Stumpf UC; Kurth A
    Med Klin (Munich); 2006 Jun; 101 Suppl 1():6-14. PubMed ID: 16826363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen-dependent increase in bone turnover and bone loss in postmenopausal women with breast cancer treated with anastrozole. Prevention with bisphosphonates.
    Confavreux CB; Fontana A; Guastalla JP; Munoz F; Brun J; Delmas PD
    Bone; 2007 Sep; 41(3):346-52. PubMed ID: 17618847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alendronate is effective to treat bone loss in renal transplantation recipients.
    Lan G; Peng L; Xie X; Peng F; Wang Y; Yu S
    Transplant Proc; 2008 Dec; 40(10):3496-8. PubMed ID: 19100422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In whom and how to prevent glucocorticoid-induced osteoporosis.
    Adachi JD; Papaioannou A
    Best Pract Res Clin Rheumatol; 2005 Dec; 19(6):1039-64. PubMed ID: 16301196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of evaluation and treatment of glucocorticoid-induced osteoporosis in men.
    Cruse LM; Valeriano J; Vasey FB; Carter JD
    J Clin Rheumatol; 2006 Oct; 12(5):221-5. PubMed ID: 17023807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bisphosphonate and mechanical stress on bone].
    Endo I; Matsumoto T
    Clin Calcium; 2008 Sep; 18(9):1321-6. PubMed ID: 18758038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone disease in organ transplant patients: pathogenesis and management.
    Chauhan V; Ranganna KM; Chauhan N; Vaid M; Kelepouris E
    Postgrad Med; 2012 May; 124(3):80-90. PubMed ID: 22691902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is treatment of early postmenopausal women with bisphosphonates justified?
    Epstein S
    Int J Clin Pract; 2007 Jun; 61(6):963-71. PubMed ID: 17504359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium and vitamin D in the prevention and treatment of osteoporosis - a clinical update.
    Boonen S; Vanderschueren D; Haentjens P; Lips P
    J Intern Med; 2006 Jun; 259(6):539-52. PubMed ID: 16704554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risks of osteoporosis associated with breast cancer treatment: the need to access to preventive treatment.
    Rozenberg S; Carly B; Liebens F; Antoine C
    Maturitas; 2009 Sep; 64(1):1-3. PubMed ID: 19709824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.